Thrifty White is offering its affiliated independent pharmacies SureCost to streamline the ordering process through a partnership with Emerlyn Technology.
Vitruvius recently received the FDA’s approval for generic Amicar, which has a market value of roughly $26.2 million.
The Food and Drug Administration has approved Mylan’s generic Lialda, which had a market value of roughly $842 million for the year ended Oct. 31, according to IQVIA data.
The Food and Drug Administration has approved Celltrion and Teva’s biosimilar to Herceptin, Herzuma (trastruzumab-pkrb).
Lupin has received the Food and Drug Administration’s OK for generic Onfi, and tentative nod for generic Adcirca, with a value of $601.2 million and $503.8 million, respectively.
NACDS vows additional advocacy efforts in light of Texas federal district court ruling to strike down the ACA.